The Contraindications to Combined Oral Contraceptives among Reproductive-Aged Women in an Obstetrics and Gynaecology Clinic: A Single-Centre Cross-Sectional Study
- PMID: 35162588
- PMCID: PMC8835169
- DOI: 10.3390/ijerph19031567
The Contraindications to Combined Oral Contraceptives among Reproductive-Aged Women in an Obstetrics and Gynaecology Clinic: A Single-Centre Cross-Sectional Study
Abstract
This study aimed to determine the estimated proportion of contraindications among women taking combined oral contraceptives (COCs) and to assess the risk factors associated with their contraindications. This study was cross-sectional. Reproductive-aged women (18-49 years) on any COCs between 2018 and 2020 were recruited from one obstetrics-gynaecology clinic in a university-affiliated hospital and were included. Contraindications were defined using the World Health Organization (WHO) Medical Eligibility Criteria (MEC) for Contraceptive Use. Data were collected from electronic medical records for all included women, as well as a standardised, pretested, structured survey for one-third of the women. In this cross-sectional study, 380 women using COCs were included. Their mean age was 31.645 ± 7.366 years. Among them, 131 (34.5%) participated via a survey and electronic records, while the other 249 (65.5%) participated via electronic records only. The majority of the participants had a Bachelor's degree (59.0%) and were married (62.1%). The overall estimated proportion of patients with at least one contraindication to COCs according to category 3 (relative contraindications) or 4 (absolute contraindications) was 31.3% (95% CI 26.63-35.99). The most common contraindications observed were controlled hypertension, category 3 (12.1%); major surgery with prolonged immobilisation, category 4 (4.7%); migraine with aura at any age, category 4 (4.2%); breastfeeding from six weeks to less than six months postpartum, category 3 (4.0%); and diabetes mellitus with complications, category 4 (3.2%). Significant factors associated with contraindications to COCs were married women (OR 2.19, 95% CI 1.38-3.46), those aged 35 years or more (OR 2.33, 95% CI 1.49-3.66), and those with one or more live births (OR 2.19, 95% CI 1.38-3.46). Ensuring proper assessment prior to prescribing and considering alternatives suitable for long-term use among women taking an oral contraceptive regularly is recommended.
Keywords: combined; contraceptive; contraindication; drug; estimated proportion; hospital; obstetrics-gynaecology department; oral; risk factors.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Combined hormonal contraception use in reproductive-age women with contraindications to estrogen use.Am J Obstet Gynecol. 2016 Sep;215(3):330.e1-7. doi: 10.1016/j.ajog.2016.03.047. Epub 2016 Apr 5. Am J Obstet Gynecol. 2016. PMID: 27059507 Free PMC article.
-
Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.Rheumatology (Oxford). 2019 Jul 1;58(7):1259-1267. doi: 10.1093/rheumatology/kez014. Rheumatology (Oxford). 2019. PMID: 30753683 Free PMC article.
-
Contraindications to combined oral contraceptives among over-the-counter compared with prescription users.Obstet Gynecol. 2011 Mar;117(3):558-565. doi: 10.1097/AOG.0b013e31820b0244. Obstet Gynecol. 2011. PMID: 21343758 Free PMC article.
-
Combined oral contraceptives: acceptability and effective use.Br Med Bull. 1993 Jan;49(1):140-57. doi: 10.1093/oxfordjournals.bmb.a072593. Br Med Bull. 1993. PMID: 8324604 Review.
-
The combined oral contraceptive. Risks and adverse effects in perspective.Drug Saf. 1995 Feb;12(2):91-6. doi: 10.2165/00002018-199512020-00002. Drug Saf. 1995. PMID: 7766340 Review.
Cited by
-
Therapeutic selection for abnormal uterine bleeding with ovulatory dysfunction: a cross-sectional study in Chinese women.Future Sci OA. 2025 Dec;11(1):2459001. doi: 10.1080/20565623.2025.2459001. Epub 2025 Feb 7. Future Sci OA. 2025. PMID: 39920891 Free PMC article.
-
Contraceptive risk events among family planning specialists: a cross sectional study.Reprod Health. 2024 Sep 13;21(1):133. doi: 10.1186/s12978-024-01870-6. Reprod Health. 2024. PMID: 39272100 Free PMC article.
-
A Multi-Institutional Informed Consent Proposal as a Prevention Tool for Combined Oral Contraceptive Intake and Thrombotic Risk.J Pers Med. 2023 Mar 27;13(4):584. doi: 10.3390/jpm13040584. J Pers Med. 2023. PMID: 37108970 Free PMC article. Review.
-
Pharmacotherapy during Pregnancy, Childbirth, and Lactation.Int J Environ Res Public Health. 2022 Sep 9;19(18):11336. doi: 10.3390/ijerph191811336. Int J Environ Res Public Health. 2022. PMID: 36141608 Free PMC article.
-
Advancements and Emerging Therapies in the Medical Management of Uterine Fibroids: A Comprehensive Scoping Review.Med Sci Monit. 2024 Jun 5;30:e943614. doi: 10.12659/MSM.943614. Med Sci Monit. 2024. PMID: 38837949 Free PMC article.
References
-
- Vrbíková J., Cibula D. Combined oral contraceptives in the treatment of polycystic ovary syndrome. [(accessed on 1 March 2021)];Hum. Reprod Update. 2005 11:277–291. doi: 10.1093/humupd/dmi005. Available online: http://academic.oup.com/humupd/article/11/3/277/758904/Combined-oral-con.... - DOI - PubMed
-
- Joseph T., Di Piro Gary C., Yee L., Posey M., Stuart T., Thomas D.H., Nolin V.E. Pharmacotherapy: A Pathophysiologic Approach. McGraw Hill; New York, NY, USA: 2020. [(accessed on 1 March 2021)]. Gynecologic and Obsetric Disorders. Available online: https://accesspharmacy.mhmedical.com/content.aspx?bookid=2577§ionid=....
-
- Assiri G.A., Shebl N.A., Mahmoud M.A., Aloudah N., Grant E., Aljadhey H., Sheikh A. What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature. [(accessed on 1 March 2021)];BMJ Open. 2018 8:e019101. doi: 10.1136/bmjopen-2017-019101. Available online: https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2017-019101. - DOI - DOI - PMC - PubMed
-
- Mosby . Mosby’s Dictionary of Medicine, Nursing & Health Professions. 11th ed. Elsevier; Amsterdam, The Netherlands: 2021. [(accessed on 1 March 2021)]. Available online: https://www.elsevier.com/books/mosbys-dictionary-of-medicine-nursing-and....
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous